Improved stability of progestogen formulations

Details for Australian Patent Application No. 2004275470 (hide)

Owner Novo Nordisk Femcare AG

Inventors Nielsen, Friis Vibeke

Agent Shelston IP

Pub. Number AU-B-2004275470

PCT Pub. Number WO2005/030176

Priority PA 2003 01408 29.09.03 DK; 60/509,962 09.10.03 US

Filing date 21 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 2 December 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030176 Priority application(s): WO2005/030176

2 December 2010 Application Accepted

  Published as AU-B-2004275470

23 December 2010 Application for Amendment

  The nature of the amendment is: Amend inventor name from Nielsen, Friis Vibeke to Nielsen Friis, Vibeke. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

14 April 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Nielsen Friis, Vibeke 2005

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275471-Prefilled packing useable as baking tin and a recipe for ingredients being prefilled in the packing

2004275469-HRT formulations